help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laidlaw, I. J.
Right arrow Articles by Anderson, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laidlaw, I. J.
Right arrow Articles by Anderson, E.

Endocrinology, Vol 136, 164-171, Copyright © 1995 by Endocrine Society

ARTICLES

The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone

IJ Laidlaw, RB Clarke, A Howell, AW Owen, CS Potten and E Anderson
Department of Surgery, University Hospital of South Manchester, United Kingdom.

In order to resolve the question of which ovarian steroid stimulates normal human mammary epithelial cell proliferation, we have implanted pieces of normal human breast tissue subcutaneously into athymic nude mice. These mice were then treated with slow-release pellets containing estradiol (E2) or progesterone (P) such that serum levels of E2 and P were increased to those seen in normal women. The proliferative activity of the tissue implants was assessed by uptake of tritiated thymidine and steroid receptor expression was measured immunocytochemically. Insertion of a 2 mg E2 pellet 14 days after tissue implantation increased the thymidine labeling index (TLI) from a median of 0.4% (n = 34) to a median of 2.1% after 7 days (n = 43; P < 0.001 by Mann Whitney U test). In contrast, treatment with a P pellet (4 mg) had no effect upon the TLI whereas P (4 mg) in combination with E2 (2 mg) had no effect over and above that of E2 alone. There was a significant correlation between the increase in TLI and either the E2 content of the pellets (P < 0.001 by linear regression) or the serum E2 levels achieved (P < 0.001). Expression of the P receptor was increased 15- to 20-fold by E2 treatment. We conclude that E2 is sufficient to stimulate human breast epithelial cell proliferation at physiologically relevant concentrations and that P does not affect proliferation either alone or after E2 priming.


This article has been cited by other articles:


Home page
 Cancer Prevention ResearchHome page
R. N. Blance, A. H. Sims, E. Anderson, A. Howell, and R. B. Clarke
Normal Breast Tissue Implanted into Athymic Nude Mice Identifies Biomarkers of the Effects of Human Pregnancy Levels of Estrogen
Cancer Prevention Research, March 1, 2009; 2(3): 257 - 264.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, and E.-E. Baulieu
Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System
Endocr. Rev., June 1, 2007; 28(4): 387 - 439.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
C L Wilson, A H Sims, A Howell, C J Miller, and R B Clarke
Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue.
Endocr. Relat. Cancer, June 1, 2006; 13(2): 617 - 628.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. A. Sartorius, D. M.E. Harvell, T. Shen, and K. B. Horwitz
Progestins Initiate a Luminal to Myoepithelial Switch in Estrogen-Dependent Human Breast Tumors without Altering Growth
Cancer Res., November 1, 2005; 65(21): 9779 - 9788.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Kuperwasser, S. Dessain, B. E. Bierbaum, D. Garnet, K. Sperandio, G. P. Gauvin, S. P. Naber, R. A. Weinberg, and M. Rosenblatt
A Mouse Model of Human Breast Cancer Metastasis to Human Bone
Cancer Res., July 15, 2005; 65(14): 6130 - 6138.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Jelovac, G. Sabnis, B. J. Long, L. Macedo, O. G. Goloubeva, and A. M.H. Brodie
Activation of Mitogen-Activated Protein Kinase in Xenografts and Cells during Prolonged Treatment with Aromatase Inhibitor Letrozole
Cancer Res., June 15, 2005; 65(12): 5380 - 5389.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Jiang, Y. E. Liu, I. D. Goldberg, and Y. E. Shi
{gamma} Synuclein, a Novel Heat-Shock Protein-Associated Chaperone, Stimulates Ligand-Dependent Estrogen Receptor {alpha} Signaling and Mammary Tumorigenesis
Cancer Res., July 1, 2004; 64(13): 4539 - 4546.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
W. Somboonporn and S. R. Davis
Testosterone Effects on the Breast: Implications for Testosterone Therapy for Women
Endocr. Rev., June 1, 2004; 25(3): 374 - 388.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Pazol, M. E. Wilson, and K. Wallen
Medroxyprogesterone Acetate Antagonizes the Effects of Estrogen Treatment on Social and Sexual Behavior in Female Macaques
J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2998 - 3006.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. Kuperwasser, T. Chavarria, M. Wu, G. Magrane, J. W. Gray, L. Carey, A. Richardson, and R. A. Weinberg
From The Cover: Reconstruction of functionally normal and malignant human breast tissues in mice
PNAS, April 6, 2004; 101(14): 4966 - 4971.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
H. Parmar, P. Young, J. T. Emerman, R. M. Neve, S. Dairkee, and G. R. Cunha
A Novel Method for Growing Human Breast Epithelium in Vivo Using Mouse and Human Mammary Fibroblasts
Endocrinology, December 1, 2002; 143(12): 4886 - 4896.
[Abstract] [Full Text] [PDF]

Home page
 Cell Growth Differ.Home page
T. K. Said, R. C. B. Moraes, U. Singh, F. S. Kittrell, and D. Medina
Cyclin-dependent Kinase (cdk) Inhibitors/cdk4/cdk2 Complexes in Early Stages of Mouse Mammary Preneoplasia
Cell Growth Differ., June 1, 2001; 12(6): 285 - 295.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. Roger, M. E. Sahla, S. Mäkelä, J. A. Gustafsson, P. Baldet, and H. Rochefort
Decreased Expression of Estrogen Receptor {beta} Protein in Proliferative Preinvasive Mammary Tumors
Cancer Res., March 1, 2001; 61(6): 2537 - 2541.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
Z. Atcha, F. R. A. Cagampang, J. A. Stirland, I. D. Morris, A. N. Brooks, F. J. P. Ebling, M. Klingenspor, and A. S. I. Loudon
Leptin Acts on Metabolism in a Photoperiod-Dependent Manner, But Has No Effect on Reproductive Function in the Seasonally Breeding Siberian Hamster (Phodopus sungorus)
Endocrinology, November 1, 2000; 141(11): 4128 - 4135.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Gandhi, P. A. Holland, W. F. Knox, C. S. Potten, and N. J. Bundred
Effects of a Pure Antiestrogen on Apoptosis and Proliferation within Human Breast Ductal Carcinoma in Situ
Cancer Res., August 1, 2000; 60(15): 4284 - 4288.
[Abstract] [Full Text]

Home page
 J Natl Cancer Inst MonogrHome page
J. Russo, Y.-F. Hu, X. Yang, and I. H. Russo
Chapter 1: Developmental, Cellular, and Molecular Basis of Human Breast Cancer
J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 17 - 37.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
C. Schairer, J. Lubin, R. Troisi, S. Sturgeon, L. Brinton, and R. Hoover
Menopausal Estrogen and Estrogen-Progestin Replacement Therapy and Breast Cancer Risk
JAMA, January 26, 2000; 283(4): 485 - 491.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
Hormone Replacement Therapy with Estrogen or Estrogen plus Medroxyprogesterone Acetate Is Associated with Increased Epithelial Proliferation in the Normal Postmenopausal Breast
J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4559 - 4565.
[Abstract] [Full Text]

Home page
 Mol. Endocrinol.Home page
C. Donaghue, B. R. Westley, and F. E. B. May
Selective Promoter Usage of the Human Estrogen Receptor-{alpha} Gene and Its Regulation by Estrogen
Mol. Endocrinol., November 1, 1999; 13(11): 1934 - 1950.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
J. P. Lydon, G. Ge, F. S. Kittrell, D. Medina, and B. W. O'Malley
Murine Mammary Gland Carcinogenesis Is Critically Dependent on Progesterone Receptor Function
Cancer Res., September 1, 1999; 59(17): 4276 - 4284.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. K. Said, O. M. Conneely, D. Medina, B. W. O'Malley, and J. P. Lydon
Progesterone, in Addition to Estrogen, Induces Cyclin D1 Expression in the Murine Mammary Epithelial Cell, in Vivo
Endocrinology, September 1, 1997; 138(9): 3933 - 3939.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. D. Graham and C. L. Clarke
Physiological Action of Progesterone in Target Tissues
Endocr. Rev., August 1, 1997; 18(4): 502 - 519.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
I. Treilleux, N. Peloux, M. Brown, and A. Sergeant
Human Estrogen Receptor (ER) Gene Promoter-P1: Estradiol-Independent Activity and Estradiol Inducibility in ER+ and ER- Cells
Mol. Endocrinol., August 1, 1997; 11(9): 1319 - 1331.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society